Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPIC: Customized vs Standard Chemotherapy in Elderly Advanced NSCLC
NCT03402048Phase 3Unknown
- Sponsor
- University of Turin
- Start
- Jul 2012
- Primary completion
- Dec 2020
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of carboplatin, gemcitabine, pemetrexed, docetaxel, vinorelbine in non-small cell lung cancer (NSCLC), sponsored by University of Turin. Status: unknown.
02
Drugs
carboplatingemcitabinepemetrexeddocetaxelvinorelbine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT03402048.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03402048.